These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11367867)

  • 1. Effect of aminoguanidine and copper(II) ions on the formation of advanced glycosylation end products. In vitro study on human serum albumin.
    Jakus V; Bauerová K; Rietbrock N
    Arzneimittelforschung; 2001; 51(4):280-3. PubMed ID: 11367867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiglycation effect of gliclazide on in vitro AGE formation from glucose and methylglyoxal.
    Li W; Ota K; Nakamura J; Naruse K; Nakashima E; Oiso Y; Hamada Y
    Exp Biol Med (Maywood); 2008 Feb; 233(2):176-9. PubMed ID: 18222972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural modifications of human albumin in diabetes.
    Guerin-Dubourg A; Catan A; Bourdon E; Rondeau P
    Diabetes Metab; 2012 Apr; 38(2):171-8. PubMed ID: 22349032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The in vitro glycation of human serum albumin in the presence of Zn(II).
    Seneviratne C; Dombi GW; Liu W; Dain JA
    J Inorg Biochem; 2011 Dec; 105(12):1548-54. PubMed ID: 22071077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
    Sakata N; Moh A; Takebayashi S
    Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycated human serum albumin as AGE-carrier protein in enzyme-linked immunosorbent assay.
    Benko B; Turk Z
    Clin Lab; 2008; 54(9-10):331-9. PubMed ID: 19097490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy.
    Stitt AW; Moore JE; Sharkey JA; Murphy G; Simpson DA; Bucala R; Vlassara H; Archer DB
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2517-23. PubMed ID: 9856760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorometric and mass spectrometric analysis of nonenzymatic glycosylated albumin.
    Zoellner H; Hou JY; Hochgrebe T; Poljak A; Duncan MW; Golding J; Henderson T; Lynch G
    Biochem Biophys Res Commun; 2001 Jun; 284(1):83-9. PubMed ID: 11374874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of quercetin in the formation of advance glycation end products of human serum albumin: An in vitro and molecular interaction study.
    Alam MM; Ahmad I; Naseem I
    Int J Biol Macromol; 2015 Aug; 79():336-43. PubMed ID: 25982953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of advanced glycation end products for biochemical studies: side chain modifications and fluorescence characteristics.
    Schmitt A; Schmitt J; Münch G; Gasic-Milencovic J
    Anal Biochem; 2005 Mar; 338(2):201-15. PubMed ID: 15745740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of supplemental L-arginine on the function of T lymphocytes and the formation of advanced glycosylated end products in rats with streptozotocin-induced diabetes.
    Liu CT; Chen KM; Lee SH; Tsai LJ
    Nutrition; 2005 May; 21(5):615-23. PubMed ID: 15850969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium sulfite and N-acetylcysteine: new additives to dialysate for inhibiting formation of glucose degradation products and advanced glycation end-products.
    Sakai A; Nakayama M; Numata M; Takesawa S; Nakamoto M
    Adv Perit Dial; 2001; 17():66-70. PubMed ID: 11510300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alginate as an antiglycating agent for human serum albumin.
    Sattarahmady N; Khodagholi F; Moosavi-Movahedi AA; Heli H; Hakimelahi GH
    Int J Biol Macromol; 2007 Jul; 41(2):180-4. PubMed ID: 17350677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversial behavior of aminoguanidine in the presence of either reducing sugars or soluble glycated bovine serum albumin.
    Serban AI; Costache M; Dinischiotu A
    Carbohydr Res; 2011 Dec; 346(18):2872-80. PubMed ID: 22063504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
    Booth AA; Khalifah RG; Hudson BG
    Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and immunological characterization of Amadori-rich human serum albumin: role in diabetes mellitus.
    Arif B; Ashraf JM; Moinuddin ; Ahmad J; Arif Z; Alam K
    Arch Biochem Biophys; 2012 Jun; 522(1):17-25. PubMed ID: 22516656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of buformin and metformin on formation of advanced glycation end products by methylglyoxal.
    Kiho T; Kato M; Usui S; Hirano K
    Clin Chim Acta; 2005 Aug; 358(1-2):139-45. PubMed ID: 15946656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.
    Lunceford N; Gugliucci A
    Fitoterapia; 2005 Jul; 76(5):419-27. PubMed ID: 15894431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of the molten globule-like state during prolonged glycation of human serum albumin.
    Sattarahmady N; Moosavi-Movahedi AA; Ahmad F; Hakimelahi GH; Habibi-Rezaei M; Saboury AA; Sheibani N
    Biochim Biophys Acta; 2007 Jun; 1770(6):933-42. PubMed ID: 17368729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of albumin glycation on the erythrocyte aggregation: an in vitro study.
    Candiloros H; Muller S; Ziegler O; Donner M; Drouin P
    Diabet Med; 1996 Jul; 13(7):646-50. PubMed ID: 8840099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.